Abstract:Background: Circulating tumor cells (CTCs) have long been considered a reflection of tumor aggressiveness. Hematogenous spreading of CTCs from a primary tumor is a crucial step in the metastasis cascade, which leads ultimately to the formation of overt metastases. However, owing to the rarity of CTCs in peripheral blood, detecting these cells requires methods combined with high sensitivity and specificity, which sets tremendous challenges for the implementation of these assays into clinical routine. Methods: Generally, CTCs detection methods are composed of the following two steps: enrichment (isolation) process (morphological and immunological techniques) and detection (identification) process (cytometric and nucleic acid techniques), which may or may not be separate from enrichment. Genetic and molecular characterization of CTCs carried out by fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH), PCR-based techniques, and biomarker immunofluorescent staining extract more information about malignant profile, metastatic potential of CTCs, and the extent to which CTCs are genetically identical to the primary tumor. Results: Recent technical advances made it possible to detect CTCs. The efficacy of circulating tumor cell (CTC) detection among patients with solid malignancy has been investigated, which shows great potential to become a tool for real-time parameter of prognosis and serve as an early marker to assess the therapeutic response in overt cancers. Improvements in detection and characterization of CTCs will hopefully lead to refinement of clinical management of cancer patients. Conclusion: This review addresses the majority of assays that have been published thus far, including the enrichment and detection steps and the markers used in these assays, accompanied by some biological issues of CTC and the results of clinical application harvested.

Current Detection Technologies for Circulating Tumor Cells.

Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical Potential

Detection of circulating tumor cells: opportunities and challenges

Advances in the Biology, Detection Techniques, and Clinical Applications of Circulating Tumor Cells

Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance

Circulating tumor cells: biology and clinical significance

Current Clinical Applications and Challenges of Circulating Tumor Cells

Clinical applications of circulating tumor cell detection: challenges and strategies

Molecular Characterization of Circulating Tumor Cells-from Bench to Bedside

Electrochemical Detection and Point-of-Care Testing for Circulating Tumor Cells: Current Techniques and Future Potentials

Advances in isolation and detection of circulating tumor cells based on microfluidics

Circulating Tumor Cells (CTCs): A Unique Model of Cancer Metastases and Non-invasive Biomarkers of Therapeutic Response

Classifying circulating tumor cells to monitor cancer progression

Application of Microfluidics in Detection of Circulating Tumor Cells

Enrichment and separation technology for evaluation of circulating tumor cells

Dissemination, detection and clinical use of circulating tumor cell

Advanced Technologies for Studying Circulating Tumor Cells at the Protein Level

Detection of Circulating Tumor Cells Using Microfluidics

Circulating Tumor Cells: How Far Have We Come with Mining These Seeds of Metastasis?

Advances in circulating tumor cells for early detection, prognosis and metastasis reduction in lung cancer